サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1683376

先進創傷治療機器の世界市場：2025年～2033年

Global Advanced Wound Care Devices Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
先進創傷治療機器の世界市場：2025年～2033年
出版日: 2025年03月20日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の先進創傷治療機器の市場規模は、2024年に38億米ドルに達し、2033年には52億2,000万米ドルに達するとみられており、2025年から2033年の予測期間中に4.3％のCAGRで拡大すると予測されています。

先進創傷治療機器市場は、創傷治癒を早め、感染症を予防し、患者の予後を改善するために設計された医療機器や技術に焦点を当てたヘルスケア産業の専門分野です。これらの器具は、細胞レベルで創傷治癒を最適化する革新的なメカニズムを取り入れることで、従来の創傷被覆材を超えるものとなっています。先進創傷治療機器には、陰圧創傷治療（NPWT）、高気圧酸素療法（HBOT）、電気刺激装置、圧迫緩和装置などがあります。

NPWTは真空システムを用いて余分な体液を除去し、治癒を促進します。HBOT装置は創傷への酸素供給を高め、細胞の修復と再生を促進します。電気刺激装置は軽度の電気インパルスを使用して細胞の活動を刺激し、血流を増加させる。圧迫緩和装置は、寝たきり患者の体重を再分配し、褥瘡のリスクを軽減します。

技術進歩は創傷治癒のための効率的で効果的かつ革新的なソリューションを促進し、先進創傷治療機器市場の重要な促進要因となっています。創傷治療技術の進化に伴い、患者の転帰の改善、治癒時間の短縮、感染制御の向上が実現されています。

小型で携帯性に優れたシステムなど、最近のNPWT機器の改良により、使いやすさと有効性が向上しています。最新のNPWTシステムは、より高度な吸引コントロールが可能で、創傷部位をより的確に治療できるため、組織の修復が早まり、創傷感染や剥離などの合併症が減少します。Smith &Nephewや3Mなどの企業は、より使いやすく在宅ケアに適した革新的なNPWTソリューションを発表しています。

業界の主要企業は、この市場成長の原動力となる製品の発売や認可を行っています。例えば、2023年6月、NovaBone Productsは、コラーゲンと45S5生体活性ガラスを組み合わせた新しい創傷ケアデバイスであるWound MatrixのFDA 510（k）認可を取得しました。この製品は、部分創傷、全層創傷、潰瘍（褥瘡、静脈性潰瘍、糖尿病性潰瘍、慢性血管性潰瘍）、手術創傷、外傷創傷、排膿創傷など様々なタイプの創傷を管理するために設計されています。これらすべての要因が、世界の先進創傷治療機器市場に需要をもたらしています。

熟練したヘルスケア提供者の不足は、世界の先進創傷治療機器市場の成長にとって大きな障壁となっています。創傷ケア技術は大きく進歩していますが、これらの機器をうまく応用できるかどうかは、看護師、医師、創傷ケアの専門家の専門知識によるところが大きいです。

陰圧創傷治療（NPWT）、電気刺激装置、生物学的治療など、多くの先進創傷治療機器は効果的に使用するために専門的なトレーニングが必要です。十分な専門知識がなければ、これらの技術を最大限に活用できない可能性があり、その結果、効果が低下して患者の転帰が最適でなくなる可能性があります。訓練が不十分であったり、機器に不慣れであったりすると、不適切な適用につながることが多いです。したがって、上記のような要因が世界の先進創傷治療機器市場の潜在的な成長を制限している可能性があります。

当レポートでは、世界の先進創傷治療機器市場について調査し、市場の概要とともに、製品タイプ別、創傷タイプ別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブの洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界の展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 先進創傷治療機器市場、製品タイプ別

  • 陰圧閉鎖療法
  • 電気療法
  • バイオフォトニック療法
  • その他

第6章 先進創傷治療機器市場、創傷タイプ別

  • 皮膚潰瘍
  • 手術創
  • 火傷
  • 糖尿病性足潰瘍
  • 褥瘡
  • 手術創
  • 術後創傷
  • その他

第7章 先進創傷治療機器市場、エンドユーザー別

  • 病院
  • 専門クリニック
  • 在宅ヘルスケア
  • その他

第8章 先進的創傷ケア機器市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第9章 競合情勢と市場ポジショニング

第10章 企業プロファイル

  • Smith+Nephew
  • Gilero
  • Pensar Medical
  • Nexa Medical Limited
  • Solventum
  • Medela
  • Alleva Medical Ltd.
  • 3M
  • Talley Group Ltd
  • DeRoyal Industries, Inc.

第11章 仮定と調査手法

第12章 付録

目次
Product Code: MD9310

The global advanced wound care devices market reached US$ 3.80 billion in 2024 and is expected to reach US$ 5.22 billion by 2033, growing at a CAGR of 4.3 % during the forecast period of 2025-2033.

The advanced wound care devices market is a specialized segment of the healthcare industry that focuses on medical devices and technologies designed to promote faster wound healing, prevent infections and enhance patient outcomes. These devices go beyond traditional wound dressings by incorporating innovative mechanisms that optimize wound healing at a cellular level. Types of advanced wound care devices include negative pressure wound therapy (NPWT), hyperbaric oxygen therapy (HBOT) devices, electrical stimulation devices and pressure relief devices.

NPWT uses a vacuum system to remove excess fluid and promote healing. HBOT devices enhance oxygen supply to wounds, boosting cell repair and regeneration. Electrical Stimulation Devices use mild electrical impulses to stimulate cell activity and increase blood flow. Pressure relief devices help redistribute weight and reduce the risk of pressure ulcers for bedridden patients.

Market Dynamics: Drivers & Restraints

Rising Technological Advancements

Technological advancements are a significant driver in the advanced wound care devices market, facilitating more efficient, effective and innovative solutions for wound healing. As wound care technologies evolve, they offer improved patient outcomes, faster healing times and better infection control.

Recent improvements in NPWT devices, such as smaller, more portable systems, have increased their usability and effectiveness. Modern NPWT systems provide a higher degree of suction control, enabling more targeted treatment of wound areas, which promotes faster tissue repair and reduces complications like wound infection and dehiscence. Companies like Smith & Nephew and 3M have introduced innovative NPWT solutions that are more user-friendly and suitable for home care settings.

Key players in the industry's product launches and approvals that would drive this market growth. For instance, in June 2023, NovaBone Products received FDA 510(k) clearance for its Wound Matrix, a novel wound care device that combines collagen and 45S5 bioactive glass. This product is designed for managing various wound types, including partial and full-thickness wounds, ulcers (pressure, venous, diabetic and chronic vascular), as well as surgical, trauma and draining wounds. All these factors demand the global advanced wound care devices market.

Shortage of Skilled Healthcare Providers

The shortage of skilled healthcare providers is a major barrier to the growth of the global advanced wound care devices market. Despite significant advancements in wound care technology, the successful application of these devices largely depends on the expertise of nurses, physicians and wound care specialists.

Many advanced wound care devices, such as negative pressure wound therapy (NPWT), electrical stimulation devices, or biological treatments, require specialized training to operate effectively. Without sufficient expertise, these technologies may not be used to their full potential, which can reduce their effectiveness and lead to suboptimal patient outcomes. Inadequate training or unfamiliarity with the devices often results in improper application. Thus, the above factors could be limiting the global advanced wound care devices market's potential growth.

Segment Analysis

The global advanced wound care devices market is segmented based on product type, wound type, end-user and region.

Product Type:

The negative pressure wound therapy segment in product type is expected to dominate the global advanced wound care devices market

Negative pressure wound therapy (NPWT) systems are FDA Class II medical devices designed to promote wound healing by applying sub-atmospheric pressure to a wound site. These systems typically include a vacuum pump, drainage tubing and a wound dressing set, which work together to remove excess fluids such as wound exudate, irrigation fluids, bodily fluids, or infectious material.

NPWT devices generate suction using either an external power source or a battery-operated vacuum system, which helps create a controlled environment for faster wound healing, reduced swelling and improved tissue regeneration. Major players in the industry innovate product launches that would propel this segment's growth in the market.

For instance, in January 2022, Smith+Nephew's introduced PICO 7 and PICO 14 negative pressure wound therapy (sNPWT) Systems were the first to be indicated for reducing both deep and superficial incisional surgical site infections (SSIs) and dehiscence. These systems use negative pressure wound therapy (NPWT), which applies suction to a wound to remove excess fluid, promote healing, and reduce infection risks. These factors have solidified the segment's position in the global advanced wound care devices market.

Geographical Analysis

North America is expected to hold a significant position in the global advanced wound care devices market

The increasing rates of diabetes, vascular diseases, and other chronic conditions have led to a higher incidence of chronic wounds, such as diabetic foot ulcers, pressure ulcers and venous leg ulcers. This has significantly boosted the demand for advanced wound care devices designed to manage and treat these complex wounds.

North America's aging population is another crucial driver. Older individuals are more susceptible to developing chronic wounds due to conditions like poor circulation, immobility and other age-related issues. As the number of elderly people rises, the need for advanced wound care solutions continues to increase.

Innovations in wound care devices, such as negative pressure wound therapy (NPWT) systems, electrical stimulation devices and biologically active dressings, are improving the speed and efficiency of wound healing. These advancements are leading to better outcomes for patients and are driving the adoption of these devices in both clinical and home settings.

Additionally, in this region, a major of key players' presence, well-advanced healthcare infrastructure, product launches and approvals would drive this market growth. For instance, in March 2023, Vaporox, a U.S.-based medical device company, secured FDA clearance for its next-generation wound care device, the VHT-200. This system is designed to treat chronic wounds, particularly those that do not respond to conventional treatments, such as diabetic foot ulcers. The VHT-200 utilizes vaporous hyperoxia therapy (VHT), which combines ultrasonic mist and concentrated oxygen to accelerate wound healing. Thus, the above factors are consolidating the region's position as a dominant force in the global advanced wound care devices market.

Competitive Landscape

The major global players in the advanced wound care devices market include Smith+Nephew, Gilero, Pensar Medical, Nexa Medical Limited, Solventum, Medela, Alleva Medical Ltd., 3M, Talley Group Ltd and DeRoyal Industries, Inc., among others.

Key Developments

  • In August 2024, Sky Medical Technology announced that its geko device is now available on India's Government e-Marketplace (GeM) procurement portal, enabling government hospitals to easily purchase the device for medical use. The Geko device is a wearable neuromuscular electrostimulation (NMES) device designed to improve blood circulation, prevent venous thromboembolism (VTE) (life-threatening blood clots), reduce post-surgical swelling (edema) in orthopedic patients, and support the healing of chronic wounds such as leg ulcers.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global advanced wound care devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Wound Type
  • 2.5. Snippet by Material
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Technological Advancements
      • 3.1.1.2. Rising Prevalence of Chronic Wounds
    • 3.1.2. Restraints
      • 3.1.2.1. Shortage of Skilled Healthcare Providers
      • 3.1.2.2. Lack of Awareness in Emerging Markets
    • 3.1.3. Opportunity
      • 3.1.3.1. Shift Toward Personalized Treatment
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Advanced Wound Care Devices Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index By Product Type
  • 5.2. Negative Pressure Wound Therapy*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Electrotherapy
  • 5.4. Biophotonic Therapy
  • 5.5. Others

6. Advanced Wound Care Devices Market, By Wound Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 6.1.2. Market Attractiveness Index By Wound Type
  • 6.2. Skin Ulcers*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Surgical Wounds
  • 6.4. Burn Wounds
  • 6.5. Diabetic Foot Ulcers
  • 6.6. Pressure Ulcers
  • 6.7. Surgical Wounds
  • 6.8. Post-Operative Wounds
  • 6.9. Others

7. Advanced Wound Care Devices Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Specialty Clinics
  • 7.4. Home Healthcare
  • 7.5. Others

8. Advanced Wound Care Devices Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Mexico
      • 8.4.6.2. Brazil
      • 8.4.6.3. Argentina
      • 8.4.6.4. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Smith+Nephew. *
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Gilero
  • 10.3. Pensar Medical
  • 10.4. Nexa Medical Limited
  • 10.5. Solventum
  • 10.6. Medela
  • 10.7. Alleva Medical Ltd.
  • 10.8. 3M
  • 10.9. Talley Group Ltd
  • 10.10. DeRoyal Industries, Inc.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us